SCHEMBL6976400

SCHEMBL6976400

COc1cc(Nc2nccc(C(=O)O)n2)cc(OC)c1OC

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PRKD3 O94806 2/20 0.58
▸ PRKCG P05129 2/20 0.58
▸ PRKCB P05771 2/20 0.58
▸ LCK P06239 2/20 0.58
▸ PRKCA P17252 2/20 0.58
▸ PRKCH P24723 2/20 0.58
▸ PRKCI P41743 2/20 0.58
▸ ZAP70 P43403 2/20 0.58
▸ PRKCE Q02156 2/20 0.58
▸ PRKCQ Q04759 2/20 0.58
▸ PRKCZ Q05513 2/20 0.58
▸ PRKCD Q05655 2/20 0.58
▸ PRKD1 Q15139 2/20 0.58
▸ IGF1R P08069 7/20 0.56
▸ CDK2 P24941 4/20 0.56
▸ EGFR P00533 3/20 0.56
▸ JAK2 O60674 1/20 0.56
▸ PIK3CA P42336 1/20 0.56
▸ PIK3CB P42338 1/20 0.56
▸ PIK3CG P48736 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6972570 0.99 PRKD3 (0.57) PRKD3PRKCGPRKCBLCKPRKCA
SCHEMBL6977468 0.87 IGF1R (0.57) PRKD3PRKCGPRKCBLCKPRKCA
SCHEMBL5549011 0.86 SMN1; SMN2 (0.61) PRKD3PRKCGPRKCBLCKPRKCA
SCHEMBL5546348 0.84 PRKD3 (0.53) PRKD3PRKCGPRKCBLCKPRKCA
SCHEMBL4229395 0.84 SYK (0.53) ZAP70IGF1RCDK2EGFRPIK3CA
SCHEMBL31650723 0.81 SMN1; SMN2 (0.54) PRKD3PRKCGPRKCBLCKPRKCA
SCHEMBL25315768 0.81 MAPT (0.55) IGF1RAURKBAURKACDK9PTK2
SCHEMBL4214061 0.80 MEN1 (0.62) PIK3CAPIK3CBPIK3CGAURKAP4HTM
SCHEMBL14088802 0.79 IGF1R (0.62) PRKD3PRKCGPRKCBLCKPRKCA
SCHEMBL1116462 0.79 IGF1R (0.79) PRKD3PRKCGPRKCBLCKPRKCA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0862560-B1 SUBSTITUTED 2-ANILINOPYRIMIDINES USEFUL AS PROTEIN KINASE INHIBITORS CELLTECH THERAPEUTICS LTD (GB) 2003-04-02 — — EP disclosed
US-6235746-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATIVE AGENT CELLTECH THERAPEUTICS, LIMITED (GB) 2001-05-22 — — US disclosed
US-5958935-A Substituted 2-anilinopyrimidines useful as protein kinase inhibitors CELLTECH THERAPEUTICS LIMITED (GB) 1999-09-28 — — US disclosed
EP-0862560-A1 SUBSTITUTED 2-ANILINOPYRIMIDINES USEFUL AS PROTEIN KINASE INHIBITORS CELLTECH THERAPEUTICS LIMITED (GB) 1998-09-09 — — EP disclosed
WO-1997019065-A1 SUBSTITUTED 2-ANILINOPYRIMIDINES USEFUL AS PROTEIN KINASE INHIBITORS CELLTECH THERAPEUTICS LIMITED (GB) 1997-05-29 — — WO disclosed
Send feedback